Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India

AK Singh, R Singh, SR Joshi, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
Background and aims There are increasing case reports of rhino-orbital mucormycosis in
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus …

Pathophysiology of COVID-19-associated acute kidney injury

M Legrand, S Bell, L Forni, M Joannidis… - Nature Reviews …, 2021 - nature.com
Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …

2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute …

Writing Committee, TJ Gluckman, NM Bhave… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of develo** documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19

ATTACC, ACTIV-4a, and REMAP-CAP … - New England Journal …, 2021 - Mass Medical Soc
Background Thrombosis and inflammation may contribute to the risk of death and
complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized …

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

TP Peacock, DH Goldhill, J Zhou, L Baillon… - Nature …, 2021 - nature.com
SARS-CoV-2 entry requires sequential cleavage of the spike glycoprotein at the S1/S2 and
the S2ʹ cleavage sites to mediate membrane fusion. SARS-CoV-2 has a polybasic insertion …

Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment

MG Mazza, M Palladini, S Poletti, F Benedetti - CNS drugs, 2022 - Springer
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic is still spreading worldwide
over 2 years since its outbreak. The psychopathological implications in COVID-19 survivors …

Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature

D Garg, V Muthu, IS Sehgal, R Ramachandran, H Kaur… - Mycopathologia, 2021 - Springer
Abstract Severe coronavirus disease (COVID-19) is currently managed with systemic
glucocorticoids. Opportunistic fungal infections are of concern in such patients. While COVID …

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

JA Müller, R Groß, C Conzelmann, J Krüger… - Nature …, 2021 - nature.com
Infection-related diabetes can arise as a result of virus-associated β-cell destruction. Clinical
data suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19

L Perico, A Benigni, F Casiraghi, LFP Ng… - Nature Reviews …, 2021 - nature.com
In December 2019, a novel coronavirus was isolated from the respiratory epithelium of
patients with unexplained pneumonia in Wuhan, China. This pathogen, named severe acute …